Esperion Therapeutics, Inc. (ESPR)
NASDAQ: ESPR · Real-Time Price · USD
3.125
-0.005 (-0.16%)
May 13, 2026, 2:43 PM EDT - Market open
Esperion Therapeutics Market Cap
Esperion Therapeutics has a market cap or net worth of $804.47 million as of May 13, 2026. Its market cap has increased by 348.43% in one year.
Market Cap
804.47M
Enterprise Value
1.19B
1-Year Change
348.43%
Ranking
Category
Stock Price
$3.13
Market Cap Chart
Since June 26, 2013, Esperion Therapeutics's market cap has increased from $204.10M to $804.47M, an increase of 294.16%. That is a compound annual growth rate of 11.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 805.80M | -8.90% |
| Dec 31, 2025 | 884.50M | 104.04% |
| Dec 31, 2024 | 433.50M | 27.50% |
| Dec 29, 2023 | 340.00M | -25.93% |
| Dec 30, 2022 | 459.00M | 215.68% |
| Dec 31, 2021 | 145.40M | -79.94% |
| Dec 31, 2020 | 724.80M | -55.52% |
| Dec 31, 2019 | 1.63B | 32.13% |
| Dec 31, 2018 | 1.23B | -28.50% |
| Dec 29, 2017 | 1.72B | 510.80% |
| Dec 30, 2016 | 282.40M | -43.67% |
| Dec 31, 2015 | 501.30M | -39.08% |
| Dec 31, 2014 | 822.90M | 290.00% |
| Dec 31, 2013 | 211.00M | 3.38% |
| Jun 26, 2013 | 204.10M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Collegium Pharmaceutical | 1.16B |
| Alvotech | 1.12B |
| Evotec SE | 1.09B |
| Xeris Biopharma Holdings | 1.06B |
| Cronos Group | 953.79M |
| Pacira BioSciences | 894.77M |
| Eton Pharmaceuticals | 816.42M |
| Amphastar Pharmaceuticals | 813.51M |